If you’ve been keeping up with the latest news in the pharmaceutical world, you might have noticed a recent buzz around Lupin Ltd. That’s right – they just received approval from the USFDA for their generic version of Tolvaptan tablets, a game-changer in the treatment of a specific type of kidney disease. So, let’s dive […]